top of page
CogMe

AI-powered Delirium Prediction, Detection, and Prevention
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
---|---|---|---|---|---|---|---|
CogMe | 02/07/2022 | NeuroreHabilitation | NeuroDegenerative | NeuralProstheses | Digital & Health care | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | 01/01/2020 | "1-10" | |
CogMe |
CogMe aims to reduce cognitive drops in at-risk populations, initially focusing on delirium in an inpatient setting. Using artificial intelligence, CogMe’s comprehensive solution will analyze the cognitive and biological indicators of individual patients to predict, detect, and intervene in order to prevent cognitive drops.
bottom of page